Page last updated: 2024-08-23

bezafibrate and Hyperchylomicronemia Late Onset

bezafibrate has been researched along with Hyperchylomicronemia Late Onset in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (50.00)	18.7374
1990's	3 (30.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachmann, C; Fragiacomo, C; Noseda, G; Weidmann, P	1
Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG	1
Barbir, M; Hunt, BJ; Kehely, A; MacMahon, M; Prescott, RJ; Thompson, GR; Wray, R	1
Mori, M; Nagai, T; Nakajima, K; Nakano, T; Saito, T; Tomizawa, T	1
Borgnino, C; Mancini, M; Mariani, M; Paoletti, R; Pauciullo, P	1
Aristegui, R; Chaves, J; Civeira, F; da Silva, PM; Díaz, C; Gómez-Gerique, JA; Hernández, A; Hernández, G; Lima, J; Mostaza, JM; Oliván, J; Pintó, X; Rodriguez-Botaro, A; Ros, E; Sol, JM; Vilardell, M; Zambón, D	1
Kudlacek, P; Sinzinger, H; Virgolini, I	1
Saito, Y; Yoshida, S	1
Bachmann, C; Fragiacomo, C; Noseda, G; Schiffl, H; Weidmann, P	1
Aviram, M; Brook, JG; Furman, B	1

Trials

5 trial(s) available for bezafibrate and Hyperchylomicronemia Late Onset

Article	Year
Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia. QJM : monthly journal of the Association of Physicians, 1995, Volume: 88, Issue:6 Topics: Adolescent; Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Simvastatin; Treatment Outcome; Triglycerides	1995
Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study). Atherosclerosis, 2000, Volume: 150, Issue:2 Topics: Adult; Aged; Bezafibrate; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Indoles; Male; Middle Aged; Safety; Treatment Outcome; Triglycerides	2000
Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. Atherosclerosis, 2002, Volume: 162, Issue:2 Topics: Adult; Atorvastatin; Bezafibrate; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Triglycerides	2002
[Effect of bezafibrate in isolated hypercholesterolemia and mixed hyperlipidemia on infarct risk (Stepwise Program for Individual Risk Identification and Therapy): an open multicenter study]. Wiener klinische Wochenschrift, 1991, Volume: 103, Issue:13 Topics: Adult; Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type V; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Triglycerides	1991
[Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]. Schweizerische medizinische Wochenschrift, 1985, Jun-29, Volume: 115, Issue:26 Topics: Adult; Aged; Alkaline Phosphatase; Bezafibrate; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Creatine Kinase; Creatinine; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Long-Term Care; Male; Middle Aged; Placebos; Triglycerides	1985

Other Studies

5 other study(ies) available for bezafibrate and Hyperchylomicronemia Late Onset

Article	Year
[The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Schweizerische medizinische Wochenschrift, 1980, Dec-06, Volume: 110, Issue:49 Topics: Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Lipoproteins, HDL; Triglycerides	1980
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Artery, 1980, Volume: 8, Issue:2 Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Inositol; Lipoproteins; Nicotinic Acids; Xanthinol Niacinate	1980
Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype. Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:5 Topics: Adult; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Bezafibrate; Cholesterol; Chylomicrons; Female; Heparin; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins, VLDL; Male; Phenotype; Triglycerides	1996
[Recent trend in the research of hyperlipidemia in Japan. Treatment of refractory hyperlipidemia]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:10 Topics: Anticholesteremic Agents; Bezafibrate; Blood Component Removal; Cholesterol; Drug Therapy, Combination; Heptanoic Acids; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Naphthalenes; Pravastatin; Probucol; Triglycerides	1989
Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function. Atherosclerosis, 1985, Volume: 56, Issue:2 Topics: Adenosine Diphosphate; Adult; Bezafibrate; Blood Platelets; Chylomicrons; Collagen; Humans; Hyperlipoproteinemia Type V; Male; Middle Aged; Platelet Aggregation; Serotonin; Thrombin; Triglycerides	1985